EC Number | Activating Compound | Comment | Organism | Structure |
---|---|---|---|---|
3.4.24.56 | amyloid beta-peptide 1-40 | - |
Rattus norvegicus | |
3.4.24.56 | beta-endorphin | - |
Rattus norvegicus | |
3.4.24.56 | bradykinin | - |
Rattus norvegicus | |
3.4.24.56 | dynorphin A-17 | - |
Rattus norvegicus | |
3.4.24.56 | dynorphin B-13 | - |
Rattus norvegicus | |
3.4.24.56 | dynorphin B-9 | 2.5fold increase in amyloid beta peptide hydrolysis | Rattus norvegicus | |
3.4.24.56 | Insulin B chain | - |
Rattus norvegicus |
EC Number | Application | Comment | Organism |
---|---|---|---|
3.4.24.56 | medicine | IDE represents a target for the development of a new class of drugs for the treatment of Alzheimer's disease that lowers amyloid beta-peptide levels by increasing ist rate of catabolism | Rattus norvegicus |
EC Number | Cloned (Comment) | Organism |
---|---|---|
3.4.24.56 | recombinant enzyme produced in Sf9 cells | Rattus norvegicus |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
3.4.24.56 | dynorphin B-9 | inhibitory with insulin as substrate | Rattus norvegicus |
EC Number | Metals/Ions | Comment | Organism | Structure |
---|---|---|---|---|
3.4.24.56 | Zn2+ | zinc metallopeptidase | Rattus norvegicus |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.4.24.56 | amyloid beta peptide 1-40 + H2O | Rattus norvegicus | physiolgical substrate | ? | - |
? | |
3.4.24.56 | insulin + H2O | Rattus norvegicus | physiolgical substrate | ? | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.4.24.56 | Rattus norvegicus | - |
rat | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.4.24.56 | 2-amino-benzoyl-GGFLRKAGQ-ethylenediamine-2,4-dinitrophenyl + H2O | - |
Rattus norvegicus | ? | - |
? | |
3.4.24.56 | 2-amino-benzoyl-GGFLRKHGQ-ethylenediamine-2,4-dinitrophenyl + H2O | - |
Rattus norvegicus | ? | - |
? | |
3.4.24.56 | 2-amino-benzoyl-GGFLRKMGQ-ethylenediamine-2,4-dinitrophenyl + H2O | - |
Rattus norvegicus | ? | - |
? | |
3.4.24.56 | amyloid beta peptide + H2O | - |
Rattus norvegicus | ? | - |
? | |
3.4.24.56 | amyloid beta peptide 1-40 + H2O | physiolgical substrate | Rattus norvegicus | ? | - |
? | |
3.4.24.56 | beta-endorphin + H2O | - |
Rattus norvegicus | ? | - |
? | |
3.4.24.56 | bradykinin + H2O | - |
Rattus norvegicus | ? | - |
? | |
3.4.24.56 | dynorphin A-17 + H2O | - |
Rattus norvegicus | ? | - |
? | |
3.4.24.56 | dynorphin B-13 + H2O | - |
Rattus norvegicus | ? | - |
? | |
3.4.24.56 | dynorphin B-9 + H2O | - |
Rattus norvegicus | ? | - |
? | |
3.4.24.56 | insulin + H2O | - |
Rattus norvegicus | ? | - |
? | |
3.4.24.56 | insulin + H2O | physiolgical substrate | Rattus norvegicus | ? | - |
? | |
3.4.24.56 | Insulin B-chain + H2O | - |
Rattus norvegicus | ? | - |
? | |
3.4.24.56 | additional information | gamma-endorphin, Leu-Arg, and Leu-enkephalin are not significantly cleaved | Rattus norvegicus | ? | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
3.4.24.56 | IDE | - |
Rattus norvegicus |
3.4.24.56 | Insulin-degrading enzyme | - |
Rattus norvegicus |